Investigating the effects of state policies on opioid prescribing for cancer pain management
Opioid Treatment of Pain in People with Cancer: Intended and unintended consequences of state policies addressing opioid prescribing
This study looks at how rules about opioid prescriptions affect cancer patients dealing with pain, helping to find the best ways to manage their discomfort while keeping safety in mind.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Weill Medical Coll of Cornell Univ NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10911247 on NIH RePORTER |
What this research studies
This research examines how state policies regarding opioid prescriptions affect cancer patients experiencing pain. It focuses on both the intended and unintended consequences of these policies, particularly for patients in different stages of cancer treatment, including those in long-term remission. By analyzing data on opioid use and related outcomes, the study aims to clarify best practices for managing pain in cancer patients while considering the ongoing opioid epidemic. The research will involve evaluating the impact of policies like Prescription Drug Monitoring Programs and dosage limits on patient care.
Who could benefit from this research
Good fit: Ideal candidates for this research include cancer patients experiencing chronic pain, particularly those in long-term remission or undergoing active treatment.
Not a fit: Patients who are not experiencing cancer-related pain or those with non-cancer pain conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved pain management strategies for cancer patients, ensuring they receive appropriate opioid therapy while minimizing risks.
How similar studies have performed: Previous research has shown that evaluating the impact of opioid prescribing policies can lead to significant improvements in patient outcomes, indicating that this approach has potential for success.
Where this research is happening
New York, United States
- Weill Medical Coll of Cornell Univ — New York, United States (Active)
Researchers
- Principal investigator: Bao, Yuhua — Weill Medical Coll of Cornell Univ
- Study coordinator: Bao, Yuhua
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.